In innovation designed to accelerate the digital transformation of pathology, Leica Biosystems has launched its latest software solutions in the Aperio Digital Pathology portfolio.
Aperio HALO AP, an advanced AI-powered image management solution, developed in conjunction with Indica Labs, provides seamless integration of digital slides and data into an intuitive interface for rapid on-screen review with comprehensive workflows, live conferencing, and collaboration.
The Aperio AI Store, exclusively available via Aperio HALO AP, is a scalable analysis platform incorporating powerful analysis applications developed by an ever-expanding number of leading innovation partners, including Deep Bio, Histofy, Indica Labs, and Lunit, all seamlessly embedded in a single interface.
Pharmaceutical companies needing AI-powered diagnostics can partner with Leica Biosystems to build custom AI applications for the AI Store and accelerate development. Built for seamless integration within Aperio HALO AP, the Aperio AI Store delivers unmatched interoperability across an end-to-end computational pathology workflow. This open, flexible platform empowers partners to streamline development, scale algorithms, and deliver new AI applications that provide insights beyond the limits of human interpretation. These unique capabilities further enable the Leica Biosystems network of pharmaceutical partnerships.